30 April 2020

Bas Bloem, theme Disorders of movement, has been appointed member of the Royal Netherlands Academy of Arts and Sciences (KNAW). Bas Bloem is among nineteen new members chosen by the KNAW this year.

The KNAW elects new members annually, based on scientific achievements. In addition to Bas Bloem, four more researchers from the Radboud campus in Nijmegen are joining the KNAW.

Bas Bloem is an expert in Parkinson's disease. He is also a healthcare innovator, focused on the integration of scientific research and its clinical applications. One example of this is ParkinsonNet, set up by Bas Bloem and human movement scientist Marten Munneke, a national network on which more than three thousand specialist Dutch Parkinson's care providers work together with each other and with patients.

Thanks to ParkinsonNet, many treatment methods have already been tested and lifestyle advice has been developed. Patients play an active part in this. This innovative approach has resulted in better quality care at lower costs and is being imitated worldwide.

Related news items


The new front line: big data podcast

22 May 2020

What role do big data and technology play in the fight against corona? What data can help save lives? How do you ensure that your personal health data is used safely? Among others, Peter-Bram 't Hoen explains.

read more

OARSI Basic Science Award for Peter van der Kraan

22 May 2020

Purpose of this Basic Science Award of the Osteoarthritis Research Society International (OARSI) is to stimulate fundamental research in the field of osteoarthritis.

read more

Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images

22 May 2020

In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.

read more

First clinical trial with genetically modified malaria vaccine completed

22 May 2020

In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.

read more

New step in the development of a vaccine against malaria

22 May 2020

A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.

read more

Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty

14 May 2020

In The Bone & Joint Journal, RIHS researcher Stan Wijn et al. showed that corticosteroid injections in the knee joint are associated with an increased risk of knee arthroplasty in patients with, or at risk of developing, symptomatic osteoarthritis of the knee.

read more